The estimated Net Worth of Kenneth F Buechler is at least $4.99 Million dollars as of 12 April 2024. Kenneth Buechler owns over 9,041 units of QuidelOrtho stock worth over $3,753,003 and over the last 17 years he sold QDEL stock worth over $1,000,000. In addition, he makes $240,055 as Independent Chairman of the Board at QuidelOrtho.
Kenneth has made over 27 trades of the QuidelOrtho stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 9,041 units of QDEL stock worth $190,494 on 12 April 2024.
The largest trade he's ever made was exercising 12,154 units of QuidelOrtho stock on 15 February 2018 worth over $197,503. On average, Kenneth trades about 2,519 units every 89 days since 2007. As of 12 April 2024 he still owns at least 83,679 units of QuidelOrtho stock.
You can see the complete history of Kenneth Buechler stock trades at the bottom of the page.
Dr. Kenneth F. Buechler serves as Independent Chairman of the Board of the Company. Dr. Buechler was previously the co-founder of and held various roles at Biosite Inc. from 1988 until its acquisition by Alere Inc. in 2007, including serving as a director and as President and Chief Scientific Officer, Senior Vice President, Research and Development, Vice President, Research and Director of Chemistry. Prior to co-founding Biosite, Dr. Buechler was a senior research scientist for the diagnostics research and development group at Hybritech Incorporated. Dr. Buechler recently served as a director of Sequenom Inc., a life sciences company until its acquisition in September 2016, Astute Medical Inc., a company that develops biomarkers for acute medical conditions until its acquisition in April 2018 and Edico Genome Inc., a DNA sequencing technology company until its acquisition in May 2018. Dr. Buechler received his Ph.D. in biochemistry and his bachelor’s degree in chemistry from Indiana University.
As the Independent Chairman of the Board of QuidelOrtho, the total compensation of Kenneth Buechler at QuidelOrtho is $240,055. There are 13 executives at QuidelOrtho getting paid more, with Douglas Bryant having the highest compensation of $4,168,770.
Kenneth Buechler is 66, he's been the Independent Chairman of the Board of QuidelOrtho since 2015. There are 4 older and 23 younger executives at QuidelOrtho. The oldest executive at QuidelOrtho Corporation is Mary Polan, 76, who is the Independent Director.
Over the last 21 years, insiders at QuidelOrtho have traded over $509,235,797 worth of QuidelOrtho stock and bought 304,015 units worth $10,385,234 . The most active insiders traders include Jack W Schuler, Matthew Strobeck, and Group Inc.Carlyle Holdings .... On average, QuidelOrtho executives and independent directors trade stock every 16 days with the average trade being worth of $1,246,606. The most recent stock trade was executed by Group Inc.Carlyle Holdings ... on 9 August 2024, trading 74,134 units of QDEL stock currently worth $3,078,785.
QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.
QuidelOrtho executives and other stock owners filed with the SEC include: